相关实验视频

Updated: Jun 8, 2025

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

Published on: January 21, 2020

设计和合成作为潜在的RET抑制剂的英多尔-2-衍生物

Zhenzhu Li¹, Kai Sun², Yuanhong Xu¹

¹Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Bioorganic & medicinal chemistry letters

|November 4, 2024

概括

研究人员开发了新型的英多尔-2-衍生物作为潜在的RET激酶抑制剂,用于抗甲状腺癌疗法. 化合物D5显示出最强的RET激酶抑制,为未来的药物开发提供了有希望的线索.

科学领域:

药用化学医学化学
在瘤学瘤学.
生物化学生化学

背景情况:

甲状腺癌的治疗仍然是一个挑战,需要新的治疗策略.
RET激酶是各种癌症的验证标,包括甲状腺癌.
醇衍生物代表了酶抑制剂开发的有前途的支架.

研究的目的:

合成和评估新型的英多尔-2-衍生物作为RET激酶的潜在抑制剂.
为了识别具有显著的RET激酶抑制活性的化合物,用于抗甲状腺癌的应用.

主要方法:

合成了五个系列的英多尔-2-衍生物.
在体外评估合成化合物对RET激酶的抑制活性.
结构-活动关系分析,以确定功效的关键结构特征.

主要成果:

包括B3,B6,D1,D2,D3和D5在内的几种印度醇-2-衍生物表现出显著的RET激酶抑制活性.
化合物D5在测试系列中表现出对RET激酶的最高抑制功效.
这些结果为进一步优化基于-2-的RET激酶抑制剂提供了基础.

结论:

印度醇-2-衍生物是RET激酶的有效抑制剂.
化合物D5是开发新型抗甲状腺癌疗法的有希望的主要候选者.
需要进一步的研究,以探索D5和相关类型在临床前和临床环境中的治疗潜力.

关键词:

细胞的增殖细胞的增殖.在RET激酶抑制剂中使用RET激酶抑制剂.结构与活动的关系.基于结构的优化优化印度尔-2-一种

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...